Raviprol

rabeprazole 20mg
Ensures fastest acid inhibitor & quickest symptom relief
Provides excellent efficacy in acid related disorders
Patients will free from the discomfort of GERD
Patients will enjoy acid related disorders free life from day-1
The Fastest Acting
Proton Pump Inhibitor in the world
Activation time (Min)
% of Complete Symptom Relief
% of Healing Rate

(Barone & Horn, 2001)
(Barnett & Robinson, 2001)
(Barnett & Robinson, 2001)
Longest Hydrophobic Side-chain ensures highest Mucin
Production
No Teratogenic Effect in Pregnancy Induced GERD
Pregnancy category
Hydrophobic
interaction of
hydrophobic side chain
with hydrophobic
structure of the cell
membrane of
mucous cell.
Stimulatory impact
on gastric mucin
production
Protection of the upper
alimentary tract from NSAID-
related mucosal injury (Kusano
et al., 2011).
Ensures better protection from NSAIDs induced mucosal injury
Prevents unpleasant sensation &
discomfort of Gastro esophageal reflux
and heartburn during pregnancy.
Better than Omeprazole which belongs
to Pregnancy Category- C (Richter,
2005).
Safer & Reliable Option for Pregnant Women
No Fetal Teratogenecity or harm to the
Fetus.
The Fastest Acting
Proton Pump Inhibitor in the world

Healing of Erosive or Ulcerative GERD 20 mg once daily
Maintenance of Healing of Erosive or Ulcerative GERD 20 mg once daily
Treatment of Symptomatic GERD 20 mg once daily
Healing of Duodenal Ulcers (Pace et al., 2007) 20 mg once daily
FDA Approved Indications & Dosage Guideline
Free from Food Interactions
Can be taken anytime - Before or
After meal
Rabeprazole
Less or no chance
of drug-drug
interaction
Moreover,
Pioneer Alu-Alu sachet
packaging for double
protection
Ensuring Health
The Fastest Acting
Proton Pump Inhibitor in the world

(Barone & Horn, 2001)
1. Barnett, J. L. & Robinson, M. (2001) Optimizing Acid-Suppression Therapy Managed Care Special Supplement. Volume 10,
No. 10.
2. Barone, J. A. and Horn, J. R. (2001) Comparative Pharmacology of Proton Pump Inhibitors Managed Care Special
Supplement. Volume 10, No. 10.
3. Kusano, M., Kuribayashi, S., Kawamura, O., Shimoyama, Y., Hosaka, H., Nagoshi, A., Zai H., and Mori, M. (2011) A Review of
the Management of Gastric Acid-Related Diseases: Focus on Rabeprazole Clinical Medicine Insights: Gastroenterology.
Vol. 3 Pp 3143
4. Pace, F., Pallotta, S., Casalini, S. and Porro, G. B. (2007) A review of rabeprazole in the treatment of acid-related diseases
Therapeutics and Clinical Risk Management. 3(3) Pages 363 - 379
5. Richter, J.E. (2005) Review article: the management of heartburn in pregnancy. Aliment Pharmacol Ther. 22(9):749-57.